| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |